IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q3 2016 Holdings

Filed 2016-11-14 | 10 holdings | $209.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$63.1K1,672,71430.1%
Aimmune Therapeutics, Inc.(AIMT)COM00900T107$59.5K3,967,90028.4%
Alder Biopharmaceuticals Inc.(ALDR1EUR)COM014339105$26.3K802,72412.6%
Universal American Corp.COM91338E101$21.6K2,820,79110.3%
Epizyme, Inc.(EPZMEUR)COM29428V104$15.2K1,543,1187.3%
NanoString Technologies, Inc.(NSTGEUR)COM63009R109$15.0K752,8577.2%
Nexvet Biopharma public limited companyORD SHSG6503X109$3.7K900,1551.8%
Zafgen, Inc.COM98885E103$2.5K760,0461.2%
Orexigen Therapeutics, Inc.COM686164104$1.8K542,7550.9%
BioDelivery Sciences International, Inc.(BDSIUSD)COM09060J106$608225,2810.3%